Year-end Sale % OFF 
Abstract
Despite advances in targeted therapies, standard chemotherapy remains the main line of treatment for most cancer patients. However, intrinsic resistance as well as acquired resistance remains an important obstacle to cancer treatment and having an impact on reducing patient’s survival. The identification of mechanisms of resistance and biomarkers that may overcome resistance to chemotherapeutic drugs is one of the main goals of cancer research. This editorial examines the recent work of Hebbar et al . (1), whose data bring out new information into the mechanisms of Par-4 action on the tumour cells chemosensitivity and their potential to overcome resistance to cancer therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
